Skip to main content

Table 2 Correlation of tumor CCT6A expression with clinical features

From: Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma

Items

Tumor CCT6A expression

P value

Low (n = 200)

High (n = 181)

Age, No. (%)

  

0.239

 ≤60.0 years

106 (53.0)

85 (47.0)

 

 >60.0 years

94 (47.0)

96 (53.0)

 

Gender, No. (%)

  

0.458

 Female

53 (26.5)

42 (23.2)

 

 Male

147 (73.5)

139 (76.8)

 

History of smoke, No. (%)

  

0.107

 No

83 (41.5)

90 (49.7)

 

 Yes

117 (58.5)

91 (50.3)

 

History of drink, No. (%)

  

0.565

 No

124 (62.0)

107 (59.1)

 

 Yes

76 (38.0)

74 (40.9)

 

Hypertension, No. (%)

  

0.774

 No

122 (61.0)

113 (62.4)

 

 Yes

78 (39.0)

68 (37.6)

 

Hyperlipidemia, No. (%)

  

0.824

 No

136 (68.0)

125 (69.1)

 

 Yes

64 (32.0)

56 (30.9)

 

Diabetes, No. (%)

  

0.479

 No

170 (85.0)

149 (82.3)

 

 Yes

30 (15.0)

32 (17.7)

 

Differentiation, No. (%)

  

0.627

 Well

35 (17.5)

21 (11.6)

 

 Moderate

112 (56.0)

116 (64.1)

 

 Poor

53 (26.5)

44 (24.3)

 

Tumor size, No. (%)

  

0.106

 ≤5.0 cm

130 (65.0)

103 (56.9)

 

 >5.0 cm

70 (35.0)

78 (43.1)

 

LYN metastasis, No. (%)

  

0.001

 No

145 (72.5)

102 (56.4)

 

 Yes

55 (27.5)

79 (43.6)

 

TNM stage, No. (%)

  

0.002

 I

82 (41.0)

49 (27.1)

 

 II

55 (27.5)

52 (28.7)

 

 III

63 (31.5)

80 (44.2)

 

CEA, No. (%)

  

0.022

 Normal (≤5.0 ng/mL)

95 (47.5)

65 (35.9)

 

 Abnormal (>5.0 ng/mL)

105 (52.5)

116 (64.1)

 
  1. Comparison was determined by chi-square test or Wilcoxon rank-sum test. CCT6A chaperonin containing TCP1 subunit 6A; LYN lymph node; CEA carcinoembryonic antigen